- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02586558
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants (CRI)
August 22, 2019 updated by: John Cairney, McMaster University
Effect of Prebiotic on Colic and Crying and Fussing Behaviour in Infants CRI Study: Colic Relief Initiative Study
Colic, or inconsolable crying and fussing, affects around 20% of babies who are 3 months of age or younger.
To date, there are no known treatments that have been found to help reduce colic and its symptoms in babies.
The investigators would like to see whether a baby formula that contains a prebiotic will lead to the same improvements in babies with colic.
The investigators will test this by giving some babies a formula with the prebiotic and other babies a placebo formula.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8P 1H6
- David Braley Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 weeks to 1 month (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy, term infant from a singleton birth (=>37 weeks gestational age); formula fed; primary caregiver able to read and write in English; current colicky behaviour
Exclusion Criteria:
- Infants with known genetic syndromes; birth weight (<2500g); use of proton pump inhibitors; use of antibiotics in previous week; use of nutritional colic remedies; use of probiotics; maternal medical history of diabetes (excluding gestational diabetes), tuberculosis, or any perinatal infection while pregnant with child enrolled in study; presence of blood in infant stool sample; possible cow milk protein allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Experimental Infant Formula
Milk-based infant formula with prebiotics
|
Ready-to-feed infant formula to be fed ad libitum
|
Placebo Comparator: Reference group
Milk-based infant formula without prebiotics
|
Ready-to-feed infant formula to be fed ad libitum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infant crying and fussing behaviour
Time Frame: 6 weeks
|
As assessed by the Barr Baby Behavior Diary
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infant crying and fussing behaviour
Time Frame: 6 weeks
|
As assessed by actigraphy and accelerometry
|
6 weeks
|
Stool Microbiota
Time Frame: 6 weeks
|
6 weeks
|
|
Stool calprotectin
Time Frame: 6 weeks
|
6 weeks
|
|
Parent satisfaction
Time Frame: 6 weeks
|
As assessed by parent survey
|
6 weeks
|
Infant behaviour
Time Frame: 6 weeks
|
As assessed by parent survey
|
6 weeks
|
Infant feeding patterns
Time Frame: 6 weeks
|
As assessed by parent survey
|
6 weeks
|
Infant stool patterns
Time Frame: 6 weeks
|
As assessed by parent survey
|
6 weeks
|
Postnatal depression
Time Frame: 6 weeks
|
As assessed by parent survey
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 13, 2017
Primary Completion (Actual)
August 15, 2019
Study Completion (Actual)
August 15, 2019
Study Registration Dates
First Submitted
October 23, 2015
First Submitted That Met QC Criteria
October 23, 2015
First Posted (Estimate)
October 26, 2015
Study Record Updates
Last Update Posted (Actual)
August 28, 2019
Last Update Submitted That Met QC Criteria
August 22, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INCH-681
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colic
-
SOFAR S.p.A.CompletedInfantile Colic | Colic, InfantileItaly
-
University of NebraskaiHealthTerminatedInfantile ColicUnited States
-
Lallemand Health SolutionsProbiSearch SLWithdrawn
-
BioGaia ABHopital Universitaire Robert-Debre; Association Clinique Thérapeutique Infantile... and other collaboratorsWithdrawnInfantile ColicFrance
-
Nordic Institute of Chiropractic and Clinical BiomechanicsResearch Unit of General Practice, OdenseCompleted
-
Innovacion y Desarrollo de Estrategias en SaludBioGaia ABUnknown
-
University of SevilleCompleted
-
University of BariAntonio Di Mauro; Ruggiero Francavilla; Lorenzo TrovèUnknown
-
Nordic Institute of Chiropractic and Clinical BiomechanicsUniversity of Southern Denmark; Foundation for the Advancement of Chiropractic...TerminatedInfantile ColicDenmark
-
Menarini GroupWithdrawn
Clinical Trials on Experimental Infant formula
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompletedGastro-Intestinal ToleranceUnited States
-
Mead Johnson NutritionBeijing Kangchen TechnologiesTerminated
-
Abbott NutritionCompletedInfant DevelopmentUnited States
-
Abbott NutritionCompleted